297 related articles for article (PubMed ID: 21667591)
1. The Minnesota Prescription Monitoring Program.
Herman C
Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
[TBL] [Abstract][Full Text] [Related]
2. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
[TBL] [Abstract][Full Text] [Related]
3. Urine drug testing in chronic pain.
Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
[TBL] [Abstract][Full Text] [Related]
4. Prescribing issues grant report to the Board of Medical Examiners. II. Minnesota Medical Association.
Minn Med; 1990 Aug; 73(8):36-42. PubMed ID: 2398844
[TBL] [Abstract][Full Text] [Related]
5. The rise in prescription drug abuse: raising awareness in the dental community.
Oakley M; O'Donnell J; Moore PA; Martin J
Compend Contin Educ Dent; 2011; 32(6):14-6, 18-22; quiz 24, 36. PubMed ID: 21894872
[TBL] [Abstract][Full Text] [Related]
6. The burden of the nonmedical use of prescription opioid analgesics.
Gilson AM; Kreis PG
Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
[TBL] [Abstract][Full Text] [Related]
7. Dental care of patients with substance abuse.
Bullock K
Dent Clin North Am; 1999 Jul; 43(3):513-26. PubMed ID: 10516924
[TBL] [Abstract][Full Text] [Related]
8. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
[TBL] [Abstract][Full Text] [Related]
9. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
10. Opioid therapy and prescription drug diversion.
Burgess FW; Pawasauskas J
Med Health R I; 2008 Sep; 91(9):268-70. PubMed ID: 18834042
[No Abstract] [Full Text] [Related]
11. The influence of prescription monitoring programs on chronic pain management.
Wang J; Christo PJ
Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
[TBL] [Abstract][Full Text] [Related]
12. Arkansas prescription monitoring program implemented.
Robertson D
J Ark Med Soc; 2013 Jun; 109(13):278-9. PubMed ID: 23808093
[No Abstract] [Full Text] [Related]
13. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.
Pauly V; Frauger E; Pradel V; Rouby F; Berbis J; Natali F; Reggio P; Coudert H; Micallef J; Thirion X
Drug Alcohol Depend; 2011 Jan; 113(1):29-36. PubMed ID: 20692778
[TBL] [Abstract][Full Text] [Related]
14. Volume of prescription opioids used nonmedically in the United States.
Katz NP; Birnbaum HG; Castor A
J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):141-4. PubMed ID: 20504136
[TBL] [Abstract][Full Text] [Related]
15. National drug control policy and prescription drug abuse: facts and fallacies.
Manchikanti L
Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
[TBL] [Abstract][Full Text] [Related]
16. Prescription opioid abuse: dental perspectives.
Jeske AH
Tex Dent J; 2005 Jul; 122(7):622-30. PubMed ID: 16152887
[TBL] [Abstract][Full Text] [Related]
17. The global diversion of pharmaceutical drugs
non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures.
Fischer B; Bibby M; Bouchard M
Addiction; 2010 Dec; 105(12):2062-70. PubMed ID: 20840172
[TBL] [Abstract][Full Text] [Related]
18. Doctor and pharmacy shopping for controlled substances.
Peirce GL; Smith MJ; Abate MA; Halverson J
Med Care; 2012 Jun; 50(6):494-500. PubMed ID: 22410408
[TBL] [Abstract][Full Text] [Related]
19. Abuse of prescription drugs and the risk of addiction.
Compton WM; Volkow ND
Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S4-7. PubMed ID: 16563663
[TBL] [Abstract][Full Text] [Related]
20. Minnesota's Prescription Monitoring Program: how to identify patients who may be abusing controlled substances.
Carter BA; Wiberg C
Minn Med; 2011 Oct; 94(10):55-6. PubMed ID: 23256287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
